Sector Spero Therapeutics, Inc. Börse Stuttgart
Stocks
2HA
US84833T1034
Biotechnology & Medical Research
|
Market Closed -
Börse Stuttgart
15:55:33 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 1.001 EUR | -1.86% |
|
-0.78% | -46.48% |
| 08-12 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.94% | +0.31% | +0.04% | +61.33% | +70.87% | +40.04% | +103.25% | +10.70% | - | 69.19B | |
| -0.07% | -2.37% | +13.36% | +13.36% | +20.70% | +33.44% | +78.50% | +206.27% | +5,900.00% | 62.97B | |
| +3.13% | +6.00% | -1.75% | +36.77% | -25.99% | -12.19% | +390.48% | +363.14% | +824.62% | 27.27B | |
| -0.54% | -3.74% | +4.76% | +14.77% | +3.08% | -4.41% | -18.31% | -70.82% | - | 24.78B | |
| -0.93% | -1.29% | +6.50% | +60.76% | +55.34% | +25.30% | +16.70% | -59.97% | - | 25.8B | |
| -1.43% | -0.61% | +6.75% | +32.46% | +5.28% | +22.71% | -19.01% | -26.24% | +107.39% | 20.11B | |
| -4.27% | +2.67% | +8.47% | +61.12% | +217.44% | +219.02% | +362.48% | +1,756.16% | +857.05% | 18.47B | |
| -1.43% | -1.80% | -10.84% | +25.92% | +22.64% | -8.64% | +537.09% | - | - | 14.88B | |
| +1.14% | +2.53% | +7.88% | +12.74% | +33.08% | +54.76% | +163.82% | +193.41% | +372.31% | 14.29B | |
| +1.50% | +23.87% | +25.64% | +24.31% | +0.29% | -9.80% | +1,038.96% | +171.10% | +182.44% | 13.79B | |
| +2.34% | +1.48% | +7.18% | +16.99% | -6.13% | +20.46% | +178.09% | +597.72% | +4,865.12% | 12.34B | |
| -2.91% | -0.13% | -5.73% | +11.87% | +24.46% | +204.12% | +176.35% | +25.48% | +980.13% | 12.02B | |
| -1.20% | +10.97% | -4.95% | +3.04% | -15.88% | -33.30% | +175.11% | +111.69% | - | 11.3B | |
| -1.65% | +3.80% | -3.45% | +9.15% | +16.64% | +42.27% | +105.52% | +138.14% | +684.23% | 10.48B | |
| -1.41% | -2.14% | +2.48% | +28.45% | +28.98% | +83.62% | +17.42% | +135.68% | - | 8.98B | |
| -2.77% | +2.41% | +5.50% | +12.41% | +307.07% | +234.44% | +524.81% | -21.60% | - | 8.79B | |
| -0.96% | -2.65% | -10.43% | +12.45% | +7.29% | -20.16% | +131.98% | -27.53% | - | 8.54B | |
| -4.25% | -1.77% | -17.14% | +20.74% | +165.35% | +422.73% | +520.93% | -52.76% | -52.56% | 8.01B | |
| -5.02% | +16.89% | +12.33% | +31.18% | +14.50% | +171.31% | +481.28% | - | - | 7.77B | |
| Average | -1.08% | +3.56% | +2.45% | +25.78% | +49.74% | +78.20% | +261.34% | +202.98% | +1,472.07% | 19.99B | |
| Weighted average by Cap. | -0.64% | +1.42% | +4.07% | +31.78% | +43.73% | +53.28% | +197.18% | +190.77% | +2,495.32% |
- Stock Market
- Stocks
- SPRO Stock
- 2HA Stock
- Sector Spero Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
